Christer Frode Aas (Christer Aas, Christer F Aas)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Substance abuse treatment, prevention, and policy

BMJ open

PLoS medicine

Addiction (Abingdon, England)

Helse Bergen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helse Bergen Sep 01 2015

Norway

Doctor :: Department of Addiction Medicine

Publications

Aaron Guanliang Lim, Christer Frode Aas, Ege Su Çağlar, Jørn Henrik Vold, Lars Thore Fadnes, Peter Vickerman, Kjell Arne Johansson
Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial. Addiction (Abingdon, England) (2023)
Christer Frode Aas, Jørn Henrik Vold, Rolf Gjestad, Svetlana Skurtveit, Aaron Guanliang Lim, Kristian Varden Gjerde, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, null null
Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Substance abuse treatment, prevention, and policy 16 (1) (2021)
Lars Thore Fadnes, Christer Frode Aas, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Ondrasova Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, null null
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS medicine 18 (6) (2021)
Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Jan Magnus Økland, Rafael Alexander Modahl Leiva, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017. BMJ open 10 (8) (2020)
Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Aaron G Lim, Kjell Arne Johansson, Lars Thore Fadnes
Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017. Substance abuse treatment, prevention, and policy 15 (1) (2020)
Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Aaron G Lim, Sabine Ruths, Kamrul Islam, Jan Erik Askildsen, Else-Marie Løberg, Lars Thore Fadnes, Kjell Arne Johansson, null null
Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Substance abuse treatment, prevention, and policy 15 (1) (2020)
Jørn Henrik Vold, Christer Frode Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Johan Reutfors, Anne Halmøy, Kjell Arne Johansson, Lars Thore Fadnes
Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ open 10 (8) (2020)

Christer Frode Aas.css-eqlu8i{font-size:small;padding-left:4px;} (Christer Aas, Christer F Aas)

Publication Activity (10 Years)

Top Topics

Top Venues

Christer Frode Aas (Christer Aas, Christer F Aas)